Conference Agenda

  • Home
  • Conference Agenda

FROM PRESENT CHALLENGES TO FUTURE SUCCESSES

ENGAGE WITH VISIONARY LEADERS, POLICYMAKERS, AND
HEALTHCARE PIONEERS TO SHAPE THE FUTURE OF ONCOLOGY

ENGAGE WITH VISIONARY LEADERS, POLICYMAKERS, AND
HEALTHCARE PIONEERS TO SHAPE THE FUTURE OF ONCOLOGY

CONFERENCE AGENDA

DAY 1: 10th September 2026
WORKSHOP AGENDA

09:00 – 10:30 Registration and Reception
10:30 – 11:45 Royal Anthem
Speech from the Executive Management of Almana Hospital
Speech from the Head of the Scientific Committee
Sponsor Recognition
Group Photo of the Speakers with the Patron of the Ceremony
Ribbon Cutting for the Accompanying Exhibition
11:45 – 13:00 Coffee / Snacks / Exhibition
13:00 – 15:00 Workshop 1: Lymphedema Workshop Dr. Feras Alshomer
Ms. Sumiah Almadani
13:00 – 17:00 Workshop 2: Breast Cryoablation / Microwave Ablation: A Novel Approach "Group A" and "Group B" Dr. Ahmed Alnammi
Dr. Afnan Almuhanna
13:00 – 15:00 Workshop 3: Supporting Cancer Patients Through Specialized Stoma Care (Stoma Care: It's More Than Just a Bag) Mr. Abdallah Sudqi
Ms. Rehab Aldossari
13:00 – 15:00 Workshop 4: Feeding Through Cancer: Practical Nutritional Management from Diagnosis to Survivorship. Ms. Hamidah Riyad Alzuhair

DAY 2: 11th September 2026
CONFERENCE AGENDA

08:00 – 08:55 REGISTRATION
08:55 – 09:00 WELCOME REMARKS Dr. NORA EBRAHIM ALMANA
BREAST CANCER SESSION
SESSION I:
TOPIC: BREAST CANCER
MODERATOR:
DR. HULAYEL MUIBED ALHARBI
DR. TAGHREED TALAL M ALHINDI
DR. AMEERA MOHAMMED ALDOSSARY
DR. FOZAN ABDULQADER F ALDULAIJAN
09:00 – 09:15 CRYOABLATION / VAE: A MINIMALLY INVASIVE ALTERNATIVE FOR BREAST SURGERY. DR. AFNAN FAHD A ALMUHANNA
09:15 – 09:30 HER2 IN BREAST CANCER FROM PATHOLOGIST PROSPECTIVE DR. MIRAL MOHAMMED O MASHHOUR
09:30 – 09:45 TARGETED PROTEIN DEGRADATION: NAVIGATING THE NEW LANDSCAPE OF ORAL SERDS AND PI3K INHIBITORS IN ENDOCRINE-RESISTANT DISEASE DR. OSAMA MAHMOUD A HALAWEH
09:45 – 10:00 NURSING PERSPECTIVE: PSYCHOLOGICAL BURDEN OF CANCER APPEARANCE CHANGES AND THE EMERGING ROLE OF COOLING CAPS DR. FATHIYYAH OMAR AL-SOMALI
10:15 – 10:30 NAVIGATING THE TOXICITIES OF ANTI-HER2 TREATMENTS: WHAT EVERY CLINICIAN SHOULD KNOW DR. SHAHID KHALID ALI ALHUMAID
10:30 – 11:00 SATELLITE SYMPOSIUM SPONSORED BY: NOVARTIS --
11:00 – 11:15 DISCUSSION / BREAK TIME
SESSION II:
TOPIC: MDT
MODERATOR:
DR. JAMILA KHALID AL AZHRI
DR. ESAM MOHAMMAD A MURSHID
DR. AHMED MOHAMMED AHMED ALWBARI
11:15 – 11:45 A.) INSEMA / SOUND (10 MINUTES) DR. MOHAMMED ABDULRAZZAQ M AL DUHILEB
B.) B-51 (10 MINUTES) DR. REEM KHALED A UJAIMI
C.) MCD AND BREAST CONSERVING SURGERY (10 MINUTES) DR. SARA K ALAJMI
11:45 – 13:00 PRAYER / LUNCH BREAK
COLORECTAL CANCER SESSION
SESSION I:
TOPIC: COLORECTAL CANCER
MODERATOR:
DR. ABDULNASSER MOHAMMED SUHAIL NOURULLAH
DR. ADNAN SALEH A. ALHEBSHI
DR. AREEJ AHMED ALBHAIR
DR. ABDULAZIZ FAHAD AL RAQTAN
13:00 – 13:15 LIQUID BIOPSY IN GENERAL WITH A FOCUS CRC: WHERE DOES IT FIT. DR. SAEED HUSSAIN M ALTURKI
13:15 – 13:30 ORGAN PRESERVING CRC OR LOCAL EXCISION DR. SULAIMAN ABDULLAH HAZZAA ALSHAMMARI
13:30 – 13:45 COLORECTAL CANCER IMMUNOTHERAPY IN THE ERA OF PRECISION MEDICINE DR. AHMAD TALAL BARHAM QUDAIH
13:45 – 14:00 PHARMACOGENOMICS IN COLORECTAL CANCER: PERSONALIZING THERAPY, IMPROVING OUTCOMES. DR. HANA ABDULLAH ABDULLATIF AL ALSHAYKH
14:00 – 14:15 SATELLITE SYMPOSIUM: TOWARD EARLIER USE OF PLUVICTO IN MCRPC SPONSORED BY: NOVARTIS DR. ABDULNASSER MOHAMMED SUHAIL NOURULLAH
SESSION II:
TOPIC: MDT
MODERATOR:
DR. AMEERA SAEED BALHARETH
DR. WALEED MOHAMMED SAEED ALSELWI
DR. SHAKIR IBRAHIM ALSHAKIR
DR. ABDULMOHSIN FAWZI S ALDILAIJAN
14:15 – 14:45 A) OLIGOMETASTATIC (15 MINUTES) DR. SULAIMAN ABDULLAH HAZZAA ALSHAMMARI
B) RECURRENCE PELVIS (15 MINUTES) DR. SULAIMAN ABDULLAH HAZZAA ALSHAMMARI
14:45 – 15:00 BREAK
LUNG SESSION
SESSION I:
TOPIC: LUNG
MODERATOR:
DR. REEM MOHAMMED ALBEESH
DR. IBRAHIM MOHAMMED ALOTAIN
DR. MANAL MOHAMMED S ALNAIMI
15:00 – 15:15 ADCS AND NEXT-GEN TKIS: OVERCOMING RESISTANCE IN EGFR AND HER2-MUTANT LUNG CANCER DR. MOHAMMED SAEED M ALGHAMDI
15:15 – 15:30 THE PRECISION RESECTION: SEGMENTECTOMY AS THE NEW GOLD STANDARD FOR STAGE 1A DR. ALLA IBRAHIM H ALGHAMEDI
15:30 – 15:45 LUNG CANCER MANAGEMENT FROM RADIATION ONCOLOGY POINT OF VIEW (SABR) DR. SALEM MOHAMMED AL SHEHRI
15:45 – 16:00 FROM BIOPSY TO BIOMARKERS: HOW PATHOLOGY DRIVES PRECISION THERAPY IN LUNG CANCER. DR. NAJD ABDULRAHMAN R ALSHAMLAN
16:00 – 16:15 ANTI-EGFR AND IMMUNE CHECK POINTS INHIBITORS TOXICITIES IN LUNG CANCER PATIENTS DR. NORA ABDULLAH ALI ALKHUDAIR
16:15 – 16:30 Q&A
16:30 CLOSING AND NETWORKING